08048035996
Zyceva 100 mg Good Quality Tablets to UK - Birmingham | Phoenix Exim | Trusted Exporter

1. General Information

Zyceva 100 mg Tablet is a prescription anticancer medicine containing erlotinib. It works by blocking signals from the epidermal growth factor receptor (EGFR), which can contribute to the growth and multiplication of certain cancer cells.

It should be used only under the supervision of a qualified oncologist, who determines whether erlotinib is appropriate based on the cancer type, molecular characteristics, previous treatment and overall health.

2. Product Information

  • Brand: Zyceva 100 mg Tablet
  • Active ingredient: Erlotinib 100 mg
  • Drug class: Tyrosine kinase inhibitor
  • Therapeutic category: Antineoplastic / targeted cancer therapy
  • Dosage form: Oral tablet
  • Manufacturer: Zydus Lifesciences
  • Typical pack: 30 tablets
  • Route: Oral administration

Official product information identifies Zyceva 100 as containing erlotinib hydrochloride equivalent to 100 mg of erlotinib.

3. Uses of Zyceva 100 mg

Zyceva 100 mg may be prescribed for:

  • Advanced or metastatic non-small-cell lung cancer (NSCLC) in appropriate patients, including tumors with specific EGFR mutations.
  • Metastatic pancreatic cancer, where erlotinib may be used in combination with gemcitabine.
  • Certain EGFR-dependent cancers where treatment with erlotinib is considered appropriate by the treating oncologist.

Treatment selection should be based on the patient's cancer diagnosis and relevant testing rather than the medicine being used solely because of the cancer's location.

4. Benefits of Zyceva 100 mg

The main potential benefits include:

  • Targeted cancer treatment: Erlotinib specifically inhibits EGFR-related signaling.
  • Slows cancer-cell growth: Blocking EGFR signaling can reduce the multiplication of susceptible cancer cells.
  • May slow disease progression: In appropriate patients, it can help control certain advanced cancers.
  • Oral treatment: It is administered as a tablet rather than by intravenous infusion.

The effectiveness of erlotinib depends on factors such as cancer type and molecular characteristics, so it is not suitable for every cancer patient.

5. Side Effects of Zyceva 100 mg

Possible side effects include:

  • Skin rash
  • Diarrhoea
  • Abdominal/stomach pain
  • Loss of appetite
  • Nausea or vomiting
  • Fatigue or weakness
  • Headache
  • Cough or shortness of breath
  • Mouth inflammation/sores
  • Changes in liver-function tests
  • Weight loss
  • Swelling in some patients

Some potentially serious reactions can occur, including severe lung inflammation, significant liver problems, gastrointestinal perforation and serious eye problems. Prompt medical attention is required for severe or unusual symptoms.

6. Common Side Effects

Commonly reported effects include:

Skin-related: rash, dry skin and increased sensitivity to sunlight.

Digestive: diarrhoea, abdominal discomfort, nausea and reduced appetite.

General: tiredness, weakness and weight loss.

The severity varies between patients. Persistent or troublesome side effects should be discussed with the treating doctor rather than stopping treatment independently.

7. How to Use Zyceva 100 mg

  • Take Zyceva exactly as prescribed by the oncologist.
  • It is generally taken once daily, unless the doctor gives different instructions.
  • Take it on an empty stomach, at least 1 hour before or 2 hours after food.
  • Swallow the tablet whole with water.
  • Do not crush, chew or break the tablet unless specifically instructed.
  • Take it at approximately the same time each day.
  • Do not change the dose or discontinue treatment without consulting your doctor.

8. How Zyceva 100 mg Works

Zyceva contains erlotinib, which blocks the tyrosine kinase activity of the epidermal growth factor receptor (EGFR).

Some cancer cells have abnormal or overactive EGFR signaling that promotes cell growth and survival. Erlotinib interferes with this signaling pathway, thereby helping to slow the growth and multiplication of susceptible cancer cells.

9. Safety Advice

Pregnancy: Erlotinib can harm an unborn baby. Women who could become pregnant should discuss effective contraception with their healthcare provider.

Breastfeeding: Breastfeeding is generally not recommended during treatment because of potential risk to the infant.

Liver disease: Tell your doctor if you have liver problems. Liver function may need monitoring and dose adjustment may be necessary.

Lung problems: Inform your doctor about existing lung disease. New or worsening cough, fever or breathing difficulty requires prompt medical evaluation.

Eye problems: Report eye pain, irritation or vision changes promptly.

Smoking: Tobacco smoking can reduce erlotinib exposure and may decrease its effectiveness; patients should discuss smoking with their healthcare provider.

Sun exposure: Erlotinib can increase sensitivity to sunlight. Use appropriate sun protection and follow your doctor's advice.

Drug interactions: Tell your doctor about all medicines, supplements and antacids you use. Acid-reducing medicines and several other drugs can affect erlotinib absorption or blood levels.

10. Frequently Asked Questions (FAQs)

Q1. What is Zyceva 100 mg used for?
Zyceva 100 mg is used for certain advanced or metastatic NSCLC and, in combination with gemcitabine, metastatic pancreatic cancer.

Q2. What is the active ingredient in Zyceva 100 mg?
It contains erlotinib 100 mg, supplied as erlotinib hydrochloride equivalent to 100 mg erlotinib.

Q3. Is Zyceva 100 mg a chemotherapy medicine?
It is an oral targeted anticancer therapy belonging to the tyrosine kinase inhibitor class rather than a conventional cytotoxic chemotherapy drug.

Q4. Should Zyceva be taken with food?
It is generally taken on an empty stomach—at least one hour before or two hours after eating.

Q5. Can I stop Zyceva if I feel better?
No. Do not stop cancer treatment without discussing it with your oncologist.

Q6. What should I do if I miss a dose?
Follow your doctor's or pharmacist's instructions. Do not double the next dose unless specifically instructed.

Q7. Does Zyceva cause skin rash?
Yes. Skin rash is a commonly reported adverse effect of erlotinib.

Q8. Is Zyceva available in different strengths?
Zyceva is also available as a 150 mg strength; the appropriate strength depends on the clinical indication and physician's prescription.

11. Substitute for Zyceva 100 mg

Possible erlotinib 100 mg alternatives include brands such as Erlotec 100 mg, Erlotad 100 mg and Birlotib 100 mg, which are listed as substitutes by Indian pharmacy references.

However, a substitute should not be selected only on the basis of the same strength. The prescribing oncologist should confirm the active ingredient, formulation, indication, manufacturer and suitability for the individual patient.

12. SEO Keywords

For Phoenix Exim's B2B/export content, you can use keywords such as:

  1. Zyceva 100 mg Tablet exporter from India
  2. Zyceva 100 mg Tablet supplier India
  3. Zyceva 100 mg Erlotinib exporter
  4. Erlotinib 100 mg Tablet exporter India
  5. Zyceva 100 mg wholesale supplier
  6. Zyceva 100 mg pharmaceutical exporter
  7. Zyceva 100 mg medicine supplier
  8. Zyceva 100 mg oncology medicine exporter
  9. Zyceva 100 mg cancer medicine supplier
  10. Erlotinib 100 mg pharmaceutical supplier India
  11. Zyceva 100 mg exporter from Nagpur
  12. Phoenix Exim Zyceva 100 mg supplier
  13. Phoenix Exim pharmaceutical exporter Nagpur
  14. Zyceva 100 mg supplier to USA
  15. Zyceva 100 mg supplier to UK
  16. Zyceva 100 mg supplier to Australia
  17. Zyceva 100 mg supplier to Singapore
  18. Zyceva 100 mg supplier to Canada
  19. Zyceva 100 mg supplier to South Korea
  20. Zyceva 100 mg supplier to UAE
  21. Erlotinib 100 mg exporter to USA
  22. Erlotinib 100 mg exporter to UK
  23. Erlotinib 100 mg exporter to Australia
  24. Erlotinib 100 mg exporter to Canada
  25. Erlotinib 100 mg exporter to UAE
  26. Erlotinib oncology medicine supplier India
  27. EGFR targeted therapy medicine exporter India
  28. Non-small cell lung cancer medicine exporter
  29. Pancreatic cancer medicine supplier India
  30. Prescription oncology medicine exporter from India
Aug 14th, 2026 3:27 PM

Keywords